chronic pain
FDA approves first new fibromyalgia therapy in over 15 years
August 18, 2025Medical Communications, Research and Development Pain, Tonix Pharmaceutical, US Food and Drug Administration, chronic pain, clinical trial, fibromyalgia
The US Food and Drug Administration (FDA) has approved Tonix Pharmaceutical’s Tonmya (cyclobenzaprine hydrochloric acid) for the treatment of fibromyalgia …
NICE recommends CBT, acupuncture, and anti-depressants for chronic pain
April 7, 2021Research and Development NICE, antidepressant, chronic pain
A new NICE guideline on the assessment and management of chronic primary pain does not recommend the prescription of painkillers, …
Blocking pain – a long-term mission for pharma research
October 5, 2011Research and Development chronic pain, neuropathic pain, pain therapeutics
Pain is a common, yet complex, clinical problem and one which remains an area of unmet need. There are however, …
FDA approves Pfizer pain drug Oxecta
June 21, 2011Sales and Marketing FDA, Oxecta, Pfizer, chronic pain
The FDA has approved Pfizer and Acura’s novel pain drug Oxecta, but will require follow up studies to prove its …
Grunenthal in talks to sell pain drug portfolio
May 19, 2011Sales and Marketing Grunenthal, Stada, chronic pain, pain therapeutics
Grunenthal is negotiating a 360 million euro deal to sell Central and Eastern European rights to some of its pain …
GSK launches global joint pain education programme
September 13, 2010Medical Communications chronic pain, disease awareness campaigns, osteoarthritis
GlaxoSmithKline has launched a global education programme to help sufferers from musculoskeletal conditions such as arthritis to self-manage pain in …
Pfizer forced to halt pain drug trials
July 20, 2010Research and Development Pfizer, chronic pain, pain therapeutics, tanezumab
Pfizer has been told by the FDA to suspend trials of its novel injectable biotherapeutic tanezumab for chronic low back …
Sanofi signs Indian pain drug development deal
May 5, 2010Research and Development Glenmark, Sanofi-Aventis, chronic pain, pain therapeutics
Sanofi-Aventis has signed an agreement with Indian firm Glenmark Pharmaceuticals to develop novel agents for the treatment of chronic pain. …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
